Clinical trial
Effectiveness of CRD-740 in Heart Failure
NCT05409183
Study timeline
Study start (actual)2022-05-26Date precision: day
Registry last updated2024-12-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
Sponsors & collaborators
Cardurion Pharmaceuticals, Inc.lead sponsor
Mapped research locations
MiamiFlorida, United States2HaifaIsrael2AtlantaGeorgia, United States1BirminghamAlabama, United States1TampaFlorida, United States1MinneapolisMinnesota, United States1TorranceCalifornia, United States1NorfolkVirginia, United States1GlasgowUnited Kingdom1GreensboroNorth Carolina, United States1HialeahFlorida, United States1Newcastle upon TyneUnited Kingdom1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05409183 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.